Abstract |
Acute myeloid leukemia (AML) in dogs is a rare disease with poor prognosis. In most subjects, palliative treatment or euthanasia is performed. A 3.5-year-old male castrated labrador with AML-M7, which was treated with induction polychemotherapy (8 cycles) using vincristine (0.5 mg/m(2)/cycle), daunorubicin (20 mg/m(2)/cycle), cytosine arabinoside ( ARA-C, 100 mg/m(2)/cycle) and prednisolone (1 mg/kg/day) is reported. Treatment was well tolerated and complete remission was achieved. Postinduction chemotherapy consisted of ARA-C, daunorubicin and prednisolone. After 3, 5 and 18 months, the subject relapsed. Each relapse was treated with ARA-C (up to 1,000 mg/m(2)) and etoposide or daunorubicin. Again, no severe side-effects occurred and the disease was controlled, with 37 chemotherapy-cycles ( ARA-C, 3 x 1,000 mg/m(2)/cycle), for 24 months. Based on a literature-search, this is the first report documenting a long-term response of canine AML, probably resulting from the high-dose ARA-C. Clinical trials using high-dose ARA-C are now required to confirm antileukemic efficacy in canine leukemias.
|
Authors | Michael Willmann, Leonhard Müllauer, Ilse Schwendenwein, Birgitt Wolfesberger, Miriam Kleiter, Maximilian Pagitz, Emir Hadzijusufovic, Sarina Shibly, Martin Reifinger, Johann G Thalhammer, Peter Valent |
Journal | In vivo (Athens, Greece)
(In Vivo)
2009 Nov-Dec
Vol. 23
Issue 6
Pg. 911-8
ISSN: 0258-851X [Print] Greece |
PMID | 20023232
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Cytarabine
- Vincristine
- Etoposide
- Prednisolone
- Daunorubicin
|
Topics |
- Animals
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Bone Marrow Cells
(drug effects, pathology)
- Cytarabine
(administration & dosage)
- Daunorubicin
(administration & dosage)
- Dog Diseases
(drug therapy)
- Dogs
- Etoposide
(administration & dosage)
- Leukemia, Megakaryoblastic, Acute
(drug therapy, pathology, veterinary)
- Male
- Prednisolone
(administration & dosage)
- Remission Induction
- Secondary Prevention
- Vincristine
(administration & dosage)
|